Differences in frequencies of drug resistance-associated mutations in the HIV-1 pol gene of B subtype and BF intersubtype recombinant samples

被引：12

作者：

Carobene, MG ^{[1
]}

Rubio, AE ^{[1
]}

Carrillo, MG ^{[1
]}

Maligne, GE ^{[1
]}

Kijak, GH ^{[1
]}

Quarleri, JF ^{[1
]}

Salomón, H ^{[1
]}

机构：

[1] Univ Buenos Aires, Sch Med, Natl Reference Ctr AIDS, Buenos Aires, DF, Argentina

来源：

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2004年 / 35卷 / 02期

关键词：

D O I：

10.1097/00126334-200402010-00018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：207 / 209

页数：3

共 10 条

[1]

Avila MM, 2002, J ACQ IMMUN DEF SYND, V29, P422, DOI 10.1097/00126334-200204010-00015

[2] Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America [J].

Carr, JK ;

Avila, M ;

Carrillo, MG ;

Salomon, H ;

Hierholzer, J ;

Watanaveeradej, V ;

Pando, MA ;

Negrete, M ;

Russell, KL ;

Sanchez, J ;

Birx, DL ;

Andrade, R ;

Vinoles, J ;

McCutchan, FE .

AIDS, 2001, 15 (15) :F41-F47

[3] Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor [J].

Condra, JH ;

Holder, DJ ;

Schleif, WA ;

Blahy, OM ;

Danovich, RM ;

Gabryelski, LJ ;

Graham, DJ ;

Laird, D ;

Quintero, JC ;

Rhodes, A ;

Robbins, HL ;

Roth, E ;

Shivaprakash, M ;

Yang, T ;

Chodakewitz, JA ;

Deutsch, PJ ;

Leavitt, RY ;

Massari, FE ;

Mellors, JW ;

Squires, KE ;

Steigbigel, RT ;

Teppler, H ;

Emini, EA .

JOURNAL OF VIROLOGY, 1996, 70 (12) :8270-8276

[4]

Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008

[5] Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs [J].

Kantor, R ;

Machekano, R ;

Gonzales, MJ ;

Dupnik, K ;

Schapiro, JM ;

Shafer, RW .

NUCLEIC ACIDS RESEARCH, 2001, 29 (01) :296-299

[6]

Kijak GH, 2001, ANTIVIR THER, V6, P71

[7] CONVERGENT COMBINATION THERAPY CAN SELECT VIABLE MULTIDRUG-RESISTANT HIV-1 IN-VITRO [J].

LARDER, BA ;

KELLAM, P ;

KEMP, SD .

NATURE, 1993, 365 (6445) :451-453

[8] QUANTITATIVE DETECTION OF HIV-1 DRUG-RESISTANCE MUTATIONS BY AUTOMATED DNA-SEQUENCING [J].

LARDER, BA ;

KOHLI, A ;

KELLAM, P ;

KEMP, SD ;

KRONICK, M ;

HENFREY, RD .

NATURE, 1993, 365 (6447) :671-673

[9] Ordered accumulation of mutations in HIV protease confers resistance to ritonavir [J].

Molla, A ;

Korneyeva, M ;

Gao, Q ;

Vasavanonda, S ;

Schipper, PJ ;

Mo, HM ;

Markowitz, M ;

Chernyavskiy, T ;

Niu, P ;

Lyons, N ;

Hsu, A ;

Granneman, GR ;

Ho, DD ;

Boucher, CAB ;

Leonard, JM ;

Norbeck, DW ;

Kempf, DJ .

NATURE MEDICINE, 1996, 2 (07) :760-766

[10] ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease [J].

Sham, HL ;

Kempf, DJ ;

Molla, A ;

Marsh, KC ;

Kumar, GN ;

Chen, CM ;

Kati, W ;

Stewart, K ;

Lal, R ;

Hsu, A ;

Betebenner, D ;

Korneyeva, M ;

Vasavanonda, S ;

McDonald, E ;

Saldivar, A ;

Wideburg, N ;

Chen, XQ ;

Niu, P ;

Park, C ;

Jayanti, V ;

Grabowski, B ;

Granneman, GR ;

Sun, E ;

Japour, AJ ;

Leonard, JM ;

Plattner, JJ ;

Norbeck, DW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) :3218-3224

← 1 →